Cohort Study of Auricular Acupressure for Postoperative Pain After Hemorrhoidectiomy
Cohort Study of Auricular Pressure Therapy for Intervention of Postoperative Pain of Hemorrhoidectiomy
1 other identifier
interventional
240
0 countries
N/A
Brief Summary
Auricular pressure is effective for postoperative analgesia after hemorrhoidectomy, but the evidence is not sufficient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2019
CompletedFirst Posted
Study publicly available on registry
October 1, 2019
CompletedStudy Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedFebruary 17, 2020
February 1, 2020
2.7 years
September 17, 2019
February 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale(VAS)
It is a unidimensional measure providing a simple solution for measuring subjective experience. The VAS scale is a 10-cm line with 0 cm indicating no symptoms and 10 cm indicates the greatest extent of symptoms.
Day 1 to 7 and month 3 and 6 after natural allocation
Secondary Outcomes (1)
Hospital Anxiety and Depression scale(HAD)
Three hours, day 3, and day 7 after natural allocation
Other Outcomes (3)
The utilization rate of analgesic drugs(Diclofenac Sodium Dual Release Enteric-coated Capsules)
Day 7 after natural allocation
Amount of analgesic drugs (Diclofenac Sodium Dual Release Enteric-coated Capsules)
Day 7 after natural allocation
Tissue edema
Day 3,day 4,day 5,day 6 and day 7 after natural allocation
Study Arms (4)
IV-PCA
EXPERIMENTALuse IV-PCA for postoperative pain
IV-dezocine
EXPERIMENTALuse IV-dezocine for postoperative pain
IV-PCA+AA
EXPERIMENTALuse IV-PCA and AA for postoperative pain
IV-dezocine+AA
EXPERIMENTALuse IV-dezocine and AA for postoperative pain
Interventions
IV-PCA contains dezocine 10mg, sufentanil 100ug, metoclopramide 20mg and normal saline are prepared into 100ml solution and pumped evenly at the speed of 2ml/h.
IV-dezocine contains dezocine 5mg and 250ml normal saline are made into solution and injected intravenously twice a day for 3 consecutive days after surgery.
IV-PCA contains dezocine 10mg, sufentanil 100ug, metoclopramide 20mg and normal saline are prepared into 100ml solution and pumped evenly at the speed of 2ml/h. And selecting the auricular points TF4, AH6a, HX2, HX5, CO4, AT4 and cowherb seeds will be attached to each auricular point after the auricle skin is disinfected. The participants will be asked to press the cowherb seeds against the auricular points every 2 hours during waking hours; each point is stimulated for one minute. Auricular points are pressed unilaterally, and the cowherb seeds will be replaced with new ones every 2 days, alternating from left to right.
IV-dezocine contains dezocine 5mg and 250ml normal saline are made into solution and injected intravenously twice a day for 3 consecutive days after surgery.And selecting the auricular points TF4, AH6a, HX2, HX5, CO4, AT4 and cowherb seeds will be attached to each auricular point after the auricle skin is disinfected. The participants will be asked to press the cowherb seeds against the auricular points every 2 hours during waking hours; each point is stimulated for one minute. Auricular points are pressed unilaterally, and the cowherb seeds will be replaced with new ones every 2 days, alternating from left to right.
Eligibility Criteria
You may qualify if:
- Meet the diagnostic criteria of grade II-IV mixed hemorrhoids and meet the operation conditions;
- Age 18\~65;
- External stripping and internal ligation of mixed hemorrhoids, general anesthesia or lumbar shu point anesthesia;
- VAS score ≥3 points;
- Sign informed consent.
You may not qualify if:
- Combined cognitive impairment could not complete the efficacy evaluation;
- With other gastrointestinal conditions found during operation;
- With severe cardiovascular, hepatic, or renal diseases;
- With opioid addiction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hui Zheng, phD
Chengdu University of Traditional Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2019
First Posted
October 1, 2019
Study Start
May 1, 2020
Primary Completion
January 1, 2023
Study Completion
May 1, 2023
Last Updated
February 17, 2020
Record last verified: 2020-02